Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2021-08-03 | 2021-08-16 | 143404 |
APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-07-27 | 2023-08-23 | 200191 |
APO-VALACYCLOVIR | 1000MG | TABLET | Resolved | 2023-11-10 | 2024-02-02 | 209961 |
APO-VALACYCLOVIR | 500MG | TABLET | Resolved | 2023-11-17 | 2024-02-02 | 210725 |
APO-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2024-05-03 | 2024-05-24 | 227031 |
APO-VALACYCLOVIR | 1000MG | TABLET | Actual shortage | 2024-05-10 | 2024-05-24 | 227714 |
APO-VALACYCLOVIR | 500MG | TABLET | Actual shortage | 2024-06-13 | 2024-06-13 | 230350 |
APO-VALGANCICLOVIR | 450MG | TABLET | Actual shortage | 2017-03-11 | 2018-02-21 | 537 |
APO-VALPROIC ACID | 250MG | CAPSULE | Resolved | 2022-09-23 | 2023-05-12 | 170115 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Actual shortage | 2023-01-30 | 2023-07-31 | 182684 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Actual shortage | 2023-06-09 | 2023-09-06 | 194593 |
APO-VALPROIC ACID ORAL SOLUTION | 50MG | SYRUP | Resolved | 2017-07-11 | 2017-08-18 | 15412 |
APO-VALSARTAN | 80MG | TABLET | Resolved | 2017-03-10 | 2019-03-08 | 272 |
APO-VALSARTAN | 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-08 | 549 |
APO-VALSARTAN | 320MG | TABLET | Resolved | 2017-03-11 | 2019-03-11 | 570 |
APO-VALSARTAN | 40MG | TABLET | Resolved | 2017-03-11 | 2019-03-11 | 573 |
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-10 | 2019-03-21 | 263 |
APO-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2017-03-10 | 2019-03-21 | 266 |
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-10 | 2019-03-21 | 269 |
APO-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2017-03-11 | 2019-03-21 | 546 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60435 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
APO-FUROSEMIDE | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60506 |
APO-FUROSEMIDE | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60509 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO GLYBURIDE TAB 2.5MG | 2.5MG | TABLET | Discontinued | 2018-09-07 | 2019-07-04 | 60515 |
APO GLYBURIDE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-14 | 60518 |
APO-HYDROCHLOROTHIAZIDE | Discontinued | 2019-11-26 | 2019-11-26 | 99653 | ||
APO-HYDROCHLOROTHIAZIDE | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60521 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60527 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60530 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
APO-METOPROLOL (TYPE L) | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60634 |
APO-METOPROLOL | 50MG | TABLET | Discontinued | 2018-09-07 | 2019-01-09 | 60631 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |